LUNG ALERT: Rapid disease progression is an important cause of death in IPF

Siddiqui, S. H.
October 2005
Thorax;Oct2005, Vol. 60 Issue 10, p833
Academic Journal
The article cites a study which reports that rapid disease progression is an important cause of death in idiopathic pulmonary fibrosis (IPF). In the study, researchers examined data generated from the placebo arm of a large multicentre double blind trial of interferon-Gama 1b in patients with mild to moderate IPF, collected over a median period of 76 weeks at 12 weekly intervals. IPF was diagnosed according to the ATS criteria, by surgical lung biopsy or established HRCT criteria in 168 patients. This study provides novel insights into the natural history of IPF.


Related Articles

  • Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Hochhaus, A.; O'Brien, S. G.; Guilhot, F.; Druker, B. J.; Branford, S.; Foroni, L.; Goldman, J. M.; Müller, M. C.; Radich, J. P.; Rudoltz, M.; Mone, M.; Gathmann, I.; Hughes, T. P.; Larson, R. A. // Leukemia (08876924);Jun2009, Vol. 23 Issue 6, p1054 

    Imatinib mesylate is considered standard of care for first-line treatment of chronic phase chronic myeloid leukemia (CML-CP). In the phase III, randomized, open-label International Randomized Study of Interferon vs STI571 (IRIS) trial, previously untreated CML-CP patients were randomized to...

  • Interference by interferons: Janus faces in vascular proliferative diseases. Wessely, Rainer // Cardiovascular Research;Jun2005, Vol. 66 Issue 3, p433 

    Abstract: Interferons (IFNs) display pleiotropic properties; not only do they protect cells from viral infections but they may also modulate cell growth and differentiation as well as innate and adaptive immune responses. Therapeutic applications of IFNs have proven efficacy in a variety of...

  • Carphology by Rajendra.  // Practical Neurology;Feb2009, Vol. 47 Issue 2, p66 

    The article focuses on the efficiency of fumerate and alemtuzumab in treating patient with relapsing-remitting multiple sclerosis. According to the author, oral fumerate can reduce the new gadolinium enhancing lesions and T2-hyperintense and T1-hypointense lesions compared with placebo. On the...

  • Tiotropium better than salmeterol for treating COPD.  // GP: General Practitioner;5/12/2003, p12 

    This article reports that Chronic Obstructive Pulmonary Disease exacerbations and health resource usage are lower among patients treated with tiotropium than those given salmeterol. The tiotropium group suffered 1.07 exacerbations per patient year, compared with 1.23 and 1.49 in the salmeterol...

  • LPS Regulates SOCS2 Transcription in a Type I Interferon Dependent Autocrine-Paracrine Loop. Jin Hu; DaoHua Lou; Carow, Berit; Winerdal, Malin E.; Rottenberg, Martin; Wikstr�m, Ann-Charlotte; Norstedt, Gunnar; Winqvist, Ola // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Recent studies suggest that SOCS2 is involved in the regulation of TLR signaling. In this study, we found that the expression of SOCS2 is regulated in human monocyte-derived DC by ligands stimulating TLR2, 3, 4, 5, 8 and 9 signaling. SOCS2 induction by LPS was dependent on the type I IFN...

  • A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Sandling, Johanna K.; Garnier, Sophie; Sigurdsson, Snaevar; Chuan Wang; Nordmark, Gunnel; Gunnarsson, Iva; Svenungsson, Elisabet; Padyukov, Leonid; Sturfelt, Gunnar; Jönsen, Andreas; Bengtsson, Anders A.; Truedsson, Lennart; Eriksson, Catharina; Rantapää-Dahlqvist, Solbritt; Mälarstig, Anders; Strawbridge, Rona J.; Hamsten, Anders; Criswell, Lindsey A.; Graham, Robert R.; Behrens, Timothy W. // European Journal of Human Genetics;Apr2011, Vol. 19 Issue 4, p479 

    Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease in which the type I interferon pathway has a crucial role. We have previously shown that three genes in this pathway, IRF5, TYK2 and STAT4, are strongly associated with risk for SLE. Here, we investigated 78 genes involved in...

  • Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo. Meng Li; Chunming Rao; Dening Pei; Lan Wang; Yonghong Li; Kai Gao; Minrong Wang; Junzhi Wang // Cancer Cell International; 

    Objective A recombinant antitumor/antiviral protein (Novaferon, Nova) is a new type of interferon, which is produced by artificial design technology combining DNA-shuffling and High Throughput Screening (HTS). Methods The in vitro biological activities, such as anti-tumor activity and antiviral...

  • Ligation of Human CD46 with Purified Complement C3b or F(ab)of Monoclonal Antibodies Enhances Isoform-Specific Interferon Gamma-Dependent Nitric Oxide Production in Macrophages1. Hirano, Akiko; Kurita-Taniguchi, Mitsue; Katayama, Yuko; Matsumoto, Misako; C. Wong, Timocy; Seya, Tsukasa // Journal of Biochemistry;2002, Vol. 132 Issue 1, p83 

    CD46, a complement regulatory protein widely expressed on human cells, serves as an entry receptor for measles virus (MV). We have previously shown that the expression of human CD46 in mouse macrophages restricts MV replication in these cells and enhances the production of nitric oxide (NO) in...

  • Diagnostic accuracy of interferon gamma-induced protein 10 for tuberculosis: a meta-analysis. Shu-Jin Guo; Liu-Qun Jia; Qian-Jing Hu; Hong-Yu Long; Cai-Shuang Pang; Fu-Qiang Wen // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 1, p93 

    The diagnostic accuracy of tuberculosis (TB) remains a clinical challenge, and a number of studies have used the interferon gamma-induced protein 10 (IP-10) in the diagnosis of TB. The aim of the present meta-analysis was to determine the overall accuracy of IP-10 in the diagnosis of TB. A...


Read the Article


Sign out of this library

Other Topics